Cardiatis is a leading brand in the field of endovascular prosthesis, specializing in the treatment of aneurysms. Their flagship product, the Multilayer Flow Modulator (MFM®), is a novel and unique platform that offers a groundbreaking solution for aneurysm treatment. The MFM® stands out due to its three-dimensional braided structure, which transforms the turbulent blood flow within the aneurysm into a laminar healing flow.

This not only reduces the risk of rupture but also removes radial stress on the artery wall. The MFM® also preserves blood flow into branch arteries and improves organ perfusion through its braided wire mesh. Furthermore, the MFM® promotes the formation of an organized thrombus inside the aneurysmal sac, providing protection against potential rupture.

The device supports endothelialization along the artery wall, while maintaining branch artery patency and creating an organized laminar flow. Cardiatis offers faster, easier, and less invasive implantation procedures, even in complex anatomies, which also reduces x-ray exposure for both patients and medical staff. The MFM® is readily available off the shelf in various sizes, with comprehensive support for planning and deployment strategies provided by the Cardiatis Corelab group.

Trust in Cardiatis and their innovative solutions for aneurysm treatment